---
schema_version: "secwatch.filing_event.v1"
accession: "0000937556-23-000063"
form_type: "8-K"
ticker: "MASI"
cik: "0000937556"
company_name: "MASIMO CORP"
filed_at: "2023-05-09T23:59:59+00:00"
generated_at: "2026-06-15T11:39:35.562915+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Masimo Q1 2023 revenue $565M (+85.7% YoY), healthcare up 14%; non-GAAP EPS $0.87 beats; FY guidance raised

## Summary
- Consolidated revenue $565.0M (+85.7% YoY); healthcare $346.7M (+14.0% reported, +15.8% constant currency).
- Non-healthcare (consumer) revenue $218.3M; GAAP EPS $0.39, non-GAAP EPS $0.87.
- Full-year 2023 guidance: consolidated revenue $2,415-2,460M; non-GAAP EPS $4.70-4.80.
- CEO cites solid performance, new hospital wins, and momentum in consumer health (Opioid Halo, Stork, Freedom pre-order).
- Healthcare growth driven by rainbow, Nomoline, Sedline, O3 monitoring uptake.

## SEC filing metadata
- accession: 0000937556-23-000063
- form_type: 8-K
- ticker: MASI
- cik: 0000937556
- company_name: MASIMO CORP
- filed_at: 2023-05-09T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/937556/000093755623000063/0000937556-23-000063-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/937556/000093755623000063/masi-20230509.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000937556-23-000063
- JSON: https://secwatch.observer/filing/0000937556-23-000063.json
- Plain text: https://secwatch.observer/filing/0000937556-23-000063.txt

## Key facts
- Earnings Releases
  MASIMO CORP reported first quarter of 2023 results: revenue $565.0 million, net income $21.3 million, EPS $0.39 per diluted share. Guidance reaffirmed.
  - Period: first quarter of 2023
  - Revenue: $565.0 million
  - Net income: $21.3 million
  - EPS: $0.39 per diluted share
  - Guidance: reaffirmed
  - Result: reported results
  source text: asimo Reports First Quarter 2023 Financial Results First Quarter 2023 Highlights • Consolidated revenue was $565.0 million; • Healthcare revenue was $346.7 million, representing 14.0% reported growth and 15.8% constant currency growth; • Non-healthcare revenue was $218.3 million; • GAAP earnings per diluted share was $0.39; and • Non-GAAP earnings per diluted share was $0.87.
  evidence_url: https://www.sec.gov/Archives/edgar/data/937556/000093755623000063/0000937556-23-000063-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.